Kanada - angleščina - Health Canada

apotex inc - saxagliptin (saxagliptin hydrochloride) - tablet - 2.5mg - saxagliptin (saxagliptin hydrochloride) 2.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Kanada - angleščina - Health Canada

apotex inc - saxagliptin (saxagliptin hydrochloride) - tablet - 5mg - saxagliptin (saxagliptin hydrochloride) 5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Kanada - angleščina - Health Canada

pro doc limitee - saxagliptin (saxagliptin hydrochloride) - tablet - 2.5mg - saxagliptin (saxagliptin hydrochloride) 2.5mg

Kanada - angleščina - Health Canada

pro doc limitee - saxagliptin (saxagliptin hydrochloride) - tablet - 5mg - saxagliptin (saxagliptin hydrochloride) 5mg

Evropska unija - angleščina - EMA (European Medicines Agency)

janssen-cilag international nv - canagliflozin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - vokanamet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated doses of metformin alonein patients on their maximally tolerated doses of metformin along with other glucose lowering medicinal products including insulin, when these do not provide adequate glycaemic control.in patients already being treated with the combination of canagliflozin and metformin as separate tabletsfor study results with respect to combination of therapies, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 500,5 mg,

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 1000,5 mg,

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 1000,2.5 mg,

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb - metformin hydrochloride, saxagliptin - film-coated tablet - 2.5, 1000 mg

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb - metformin hydrochloride, saxagliptin - film-coated tablet - 5, 1000 mg